SCHEMBL21776106

SCHEMBL21776106

CC(S)N1CCC2(CC[C@H]2N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22048913 1.00 — —
SCHEMBL21451657 0.89 PTPN11 (0.34) —
SCHEMBL21887304 0.89 PTPN11 (0.34) —
SCHEMBL19756492 0.84 CYP2D6 (0.40) —
SCHEMBL21451660 0.84 CYP2D6 (0.40) —
SCHEMBL21451639 0.84 CYP2D6 (0.40) —
SCHEMBL19756479 0.77 CYP2D6 (0.34) —
SCHEMBL22520410 0.75 PTPN11 (0.37) —
SCHEMBL22393475 0.75 PTPN11 (0.37) —
SCHEMBL22393613 0.75 PTPN11 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200062760-A1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2020-02-27 — — US disclosed
Send feedback